TTS containing an antioxidant

US6316023A · kind A · utility

Assignees

• Novartis AG · CH
• LTS Lohmann Therapie-Systeme AG · DE

Inventors

• Bodo Asmussen · Bendorf, DE
• Michael Horstmann · Neuwied, DE
• Kai Kopke · Triengen, CH
• Henricus Tiemessen · Weil am Rhein, DE
• Steven Dinh · Burlington, US
• Paul M. Gargiulo · New York, US

Key dates

• Filing date: Dec 20, 2000
• Grant date: Nov 13, 2001
• Expiry date: Dec 20, 2020

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61K31/27
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

Pharmaceutical composition comprising (S)-N-ethyl-3-[1-dimethylamino)ethyl]-N-methyl-phenyl-carbamate in free base or acid addition salt form and an antioxidant. Said pharmaceutical compositions may be delivered to a patient using a transdermal delivery device.